European Archives - Page 272 of 1154 - European Medical Journal

Sanofi's MS drug delivers surprising Phase III results

It’s been both a good and bad week for French pharmaceutical company Sanofi, as their MS drug candidate, received mixed trial results.

Polycystic Ovary Syndrome Linked to Disordered Eating

Women with polycystic ovary syndrome are at a greater risk for developing disordered eating according to the results of a meta-analysis.

Penile Curvature Study Reveals New Peyronie’s Disease Classification

A new classification system for Peyronie’s disease, has been introduced in a recent study aiming to better define the subtypes and stages of this condition

AI Could Lighten Urologists’ Administrative Workload

A study has suggested that generative AI tools could potentially reduce the time burden of electronic health record management for urologists.

Optimising Methotrexate for Arthritis

Listen to three experts attending EULAR 2024, who provide their recommendations on how to optimise methotrexate therapy use across various arthritis types.

Patient Perspectives of Navigating Life with Primary Biliary Cholangitis

Transplant hepatologist Eleonora De Martin and patient advocate Ingo van Thiel, co-host this bonus episode to support the continuing education of healthcare professionals working with primary biliary cholangitis. NX-GBL-LNR-AUDI-240001 | May 2024

Primary Parotid Tuberculosis Presenting as a Malignancy

Tuberculosis is a well-known endemic disease in India; however, extra-pulmonary tuberculosis in the form of single parotid gland…

SHAM-PVI Trial Confirms Efficacy of Ablation Procedure for Atrial Fibrillation: ESC 2024

ESC 2024: The SHAM-PVI trial confirms that catheter ablation significantly reduces atrial fibrillation burden and improves quality of life compared to a sham treatment.

Optical Coherence Tomography for Stent Guidance Improves Outcomes in Complex PCI Cases: ESC 2024

ESC 2024: OCT-guided PCI in complex lesions reduced cardiac risks by 38% and spontaneous MI by 64% versus angiography, according to the OCCUPI trial.

Wearable ECG Device for Atrial Fibrillation Screening: ESC 2024

Atrial fibrillation screening using a 14-day wearable heart monitor patch significantly increased diagnoses compared to usual care, according to research presented at ESC 2024.